Hypothesis
Inter‑omics discordance—specifically, a divergence where epigenetic age indicates younger biological state while proteomic age indicates older state—reflects organ‑specific accumulation of senescence‑associated secretory phenotype (SASP) proteins that are not captured by DNA methylation clocks, a limitation noted in multi-omics integration approaches 1. We hypothesize that this epigenetic‑proteomic age gap predicts imminent functional decline in the organ system contributing the majority of the discordant proteomic signal, and that targeted reduction of SASP (e.g., via senolytics or NAD⁺ boosters) will narrow the gap and delay clinical frailty.
Mechanistic Rationale
Epigenetic clocks primarily measure cell‑intrinsic chromatin modifications that change slowly and are relatively resistant to acute extracellular fluctuations. In contrast, plasma proteomic clocks are highly responsive to secreted factors, including SASP cytokines, chemokines, and matrix remodelers that surge when tissue‑resident senescent cells expand. When a tissue undergoes stress‑induced senescence, its epigenome may not yet have accrued the methylation changes needed to shift the epigenetic clock, while the secretome rapidly alters the proteomic clock, producing a younger epigenetic readout alongside an older proteomic readout. This mismatch therefore serves as an early warning of tissue‑specific frailty before global epigenetic aging catches up. Such tissue‑specific signatures have been missed in prior digital twin models that achi





























